Benzinga’s “After-Hours Movers & Information” highlights the largest movers of the day. The knowledge on the worth motion is collected utilizing Benzinga Professional’s Movers instrument.
Benzinga Professional customers can cross-reference the Movers instrument with the Benzinga Professional Information instrument to establish potential information catalysts shifting shares.
See Additionally: Markets Fall Once more As Russia-Ukraine Battle Erodes Investor Sentiment
Movers
- 36KR Holdings (NASDAQ: KRKR) +36.76%
- Recruiter.com Group (NASDAQ: RCRT) +16.83%: The Recruiter Index confirmed that the job-hopper economic system is in full swing. Twenty-six % of recruiters reported that lots of the candidates they have been taking a look at have had three jobs over the previous two years.
- AnPac Bio-Medical Science (NASDAQ: ANPC) +11.81%: introduced that on March 8, it obtained a written discover from the Nasdaq indicating the corporate isn’t in compliance with the minimal bid value requirement of $1.00 per share underneath the Nasdaq Itemizing Guidelines. It is not a discover of imminent delisting, and it has no present fast impact on the itemizing or buying and selling of the corporate’s securities on the Nasdaq Capital Market.
- CVRx (NASDAQ: CVRX) +11.62%
- WeWork (NYSE: WE) +11.46%: WeWork expects to ship between $3.8 and $4 billion systemwide income in 2022. On a consolidated foundation, the corporate expects to ship between $3.35 and $3.5 billion income in 2022, together with between $740 and $760 million of income in Q1 and between $775 and $825 million of income in Q2.
Losers
- Waitr Holdings (NASDAQ: WTRH) -17.07%: Reported income for the fourth quarter of 2021 was $38.6 million, in comparison with $46.8 million for the fourth quarter of 2020. Internet loss for the fourth quarter of 2021 was $8.1 million, or $0.06 per share, in comparison with web revenue of $2.6 million within the fourth quarter of 2020, or $0.02 per share.
- Shineco (NASDAQ: SISI) -12.34%
- Immunome, Inc (NASDAQ: IMNM) -10.95%: The FDA has lifted the medical maintain on the corporate’s Investigational New Drug (IND) utility for its antibody cocktail to deal with COVID-19.
- Avinger (NASDAQ: AVGR) -9.91%
© 2022 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.